The Post-MI Patient: A GP's practical guide to lipid lowering, PCSK9 inhibition on Repatha® (evolocumab)
00:06 Introduction
03:06 Why is preventing plaque rupture important?
05:41 Why Lowest LDL-C is Best
07:19 Mecanism of Action
10:54 Repatha’s Efficacy data
12:15 Repatha’s Safety profile
15:59 How to access Repatha on PBS
16:55 Key Takeaways and Q&As
Do you want to link to this Amgen Site outside the UK and leave amgenhealthcareinnovationhub.co.uk?
YOU ARE NOW LEAVING THIS WEBSITE. Amgen Limited and Amgen Ireland Limited takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.
